Table 1 Patient characteristics.
patient characteristics | Zurich | Montreal | P |
|---|---|---|---|
(n = 32) | (n = 52) | ||
Host factors | |||
Age (years) | 61 ± 13 | 56 ± 12 | 0.07 |
gender (% female) | 69 | 62 | |
Anatomical extent tumor size (%) | |||
T1 | 13 | 15 | |
T2 | 28 | 38 | |
T3 | 38 | 21 | |
T4 | 22 | 23 | |
LN involvement (%) | 0.08 | ||
N0 | 43 | 71 | 0.01 |
N1 | 17 | 8 | |
N2 | 23 | 10 | |
N3 | 17 | 12 | |
Treatment-related factors | |||
RT (Gy) | 59.4 ± 1 | 52.1 ± 2 | < 0.001 |
RT duration (days) | 52 ± 8 | 50 ± 8 | |
Split duration (days) | 6 ± 8 | 14 ± 7 | < 0.001 |
Inguinal RT (%) | 56 | 98 | <0.001 |
Chemotherapy (%) | 81 | 100 | <0.01 |
MMC (%) | 78 | 98 | <0.01 |